Does PRAZAXA Cause Activated partial thromboplastin time prolonged? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Activated partial thromboplastin time prolonged have been filed in association with PRAZAXA. This represents 5.0% of all adverse event reports for PRAZAXA.
8
Reports of Activated partial thromboplastin time prolonged with PRAZAXA
5.0%
of all PRAZAXA reports
0
Deaths
5
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From PRAZAXA?
Of the 8 reports, 5 (62.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PRAZAXA. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does PRAZAXA Cause?
Cerebral infarction (20)
Embolic stroke (12)
Drug ineffective (10)
Cardiac failure (9)
Interstitial lung disease (8)
Cardiac failure chronic (6)
Fall (6)
Death (5)
Renal impairment (5)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which PRAZAXA Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
PRAZAXA vs PRAZEPAM
PRAZAXA vs PRAZIQUANTEL
PRAZAXA vs PRAZOSIN
PRAZAXA vs PREDNICARBATE
PRAZAXA vs PREDNISOLONE